Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 68   

Articles published

AZN 4,750.00 -78.50 (-1.63%)
price chart
AstraZeneca Is Undervalued
AstraZeneca plc is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and ...
AstraZeneca Antitrust Fine Should Stand, EU Court Aide Says
May 15 (Bloomberg) -- AstraZeneca Plc, the U.K.'s second-biggest drugmaker, shouldn't get a further reduction in an antitrust fine of 52.5 million euros ($67.5 million), an adviser to the European Union's highest court said.
Related articles »  
Amylin Said to Attract Interest From Pfizer, AstraZeneca
May 15 (Bloomberg) -- Amylin Pharmaceuticals Inc. has lured suitors such as Pfizer Inc., AstraZeneca Plc and Sanofi, which signed confidentiality agreements on the drugmaker's sale process, said people familiar with the matter.
Related articles »  
William Hill stands by CEO amid shareholder revolt
William Hill (WMH) was the latest company to respond to shareholder outrage over executive pay. The bookmaking giant rushed to the defence of chief executive Ralph Topping's �1.2 million bonus on Tuesday as it countered the shareholder rebellion at its ...
William Hill chief Ralph Topping narrowly wins pay vote  Telegraph.co.uk
Related articles »  
Aviva chief resigns after shareholder uprising
The resignation of Moss followed the high-profile exits of Sly Bailey from Trinity Mirror and David Brennan from AstraZeneca last week as a result of shareholder hostility. Aviva shares, which have fallen a third in a year, were up 4% on the news. Lord ...
UK Pay Protests Oust Aviva Chief  Wall Street Journal
Related articles »  
EU Joins Widening Push to Find New Antibiotics
"Antibiotics are fundamental for the practice of medicine," says John Rex, vice-president of clinical infection at AstraZeneca AZN 1.25 % PLC." Without them you cannot get your heart valve replaced, take care of a premature infant, get your cancer ...
Related articles »  
Welcome Shareholder Spring That Holds Bosses to Account
... big British insurer, balked at the board's plans for top executives' compensation, the CEO resigned. It has spread beyond pay, too.
Related articles »  
US to Seek New Uses for Abandoned Drugs
The National Institutes of Health initially will work with Pfizer Inc., PFE -0.17 % Eli Lilly LLY -0.08 % & Co. and AstraZeneca AZN 3.17 % PLC to match abandoned drugs with researchers from universities, hospitals and the NIH. Researchers at the NIH's ...
US to partner with Big Pharma for drug discovery  Fox News
Related articles »  
Shareholder spring: After the unseating of big beasts, no overpaid executive ...
Sly Bailey of Trinity Mirror and David Brennan of AstraZeneca have been defenestrated due to a toxic mix of large rewards and lacklustre returns.
Related articles »  
Drugmakers see $33bn bout of M&A activity
While the appetite for �mega mergers� has dulled, several midsize companies including Shire and Biogen Idec are regularly cited as potential targets.